[1] ANURADHA S, JOSHI A, NEGI M, et al. Factors influencing adherence to ART: new insights from a center providing free ART under the national program in Delhi, India [J]. J Int Assoc Provid AIDS Care, 2013, 12(3): 195-201. [2] PRESS CENTRE. UNAIDS report shows that 19 million of the 35 million people living with HIV today do not know that they have the virus [EB/OL]. [2014-7-16].http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2014/july/20140716prgapreport. [3] 本报记者 陈飞. 终结艾滋病 难过三个“九成”关 [N]. 健康报.2014-08-26. [4] 2014年10月全国艾滋病性病疫情及主要防治工作进展 [J]. 中国艾滋病性病, 2014,12: 885. [5] MEMIAH P, SHUMBA C, ETIENNE-MESUBI M, et al. The effect of depressive symptoms and CD4 count on adherence to highly active antiretroviral therapy in sub-Saharan Africa [J]. J Int Assoc Provid AIDS Care, 2014, 13(4): 346-52. [6] 本书编写组. 国家免费艾滋病抗病毒药物治疗手册 [M]. 第3版.北京:人民卫生出版社, 2012: 141. [7] ABAASA A M, TODD J, EKORU K, et al. Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda [J]. BMC health services research, 2008, 8: 241. [8] NEL A, KAGEE A. Common mental health problems and antiretroviral therapy adherence [J]. AIDS care, 2011, 23(11): 1360-5. [9] MORRISON S D, RASHIDI V, SARNQUIST C, et al. Antiretroviral therapy adherence and predictors to adherence in Albania: a cross-sectional study [J]. Journal of infection in developing countries, 2014, 8(7): 853-62. [10] NANNI M G, CARUSO R, MITCHELL A J, et al. Depression in HIV infected patients: a review [J]. Current psychiatry reports, 2015, 17(1): 530. [11] PENCE B W. The impact of mental health and traumatic life experiences on antiretroviral treatment outcomes for people living with HIV/AIDS [J]. The Journal of antimicrobial chemotherapy, 2009, 63(4): 636-40. [12] ALFONSO V, GELLER J, BERMBACH N, et al. Becoming a "treatment success": what helps and what hinders patients from achieving and sustaining undetectable viral loads [J]. AIDS patient care and STDs, 2006, 20(5): 326-34. [13] CAMPOS L N, GUIMARAES M D, REMIEN R H. Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil [J]. AIDS and behavior, 2010, 14(2): 289-99. [14] 韩婷婷, 霍瑞雪, 张天琦. 艾滋病患者抑郁状况及其影响因素的述评 [J]. 中国当代医药, 2011, 23: 23-4. [15] NYAMATHI A, HERAVIAN A, SALEM B, et al. Physical and mental health of rural southern Indian women living with AIDS [J]. J Int Assoc Provid AIDS Care, 2013, 12(6): 391-6. [16] COOK J A, GREY D, BURKE J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women [J]. American journal of public health, 2004, 94(7): 1133-40. [17] KINYANDA E, HOSKINS S, NAKKU J, et al. Prevalence and risk factors of major depressive disorder in HIV/AIDS as seen in semi-urban Entebbe district, Uganda [J]. BMC psychiatry, 2011, 11:205. [18] WILLIAMS P, NARCISO L, BROWNE G, et al. The prevalence, correlates, and costs of depression in people living with HIV/AIDS in Ontario: implications for service directions [J]. AIDS education and prevention : official publication of the International Society for AIDS Education, 2005, 17(2): 119-30. [19] BING E G, BURNAM M A, LONGSHORE D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States [J]. Archives of general psychiatry, 2001, 58(8): 721-8. [20] KAIDA A, MATTHEWS L T, ASHABA S, et al. Depression during pregnancy and the postpartum among HIV-infected women on antiretroviral therapy in Uganda [J]. Journal of acquired immune deficiency syndromes (1999), 2014, 67 (Suppl 4):S179-S187. [21] SONG J Y, LEE J S, SEO Y B, et al. Depression Among HIV-infected Patients in Korea: Assessment of Clinical Significance and Risk Factors [J]. Infection & chemotherapy, 2013, 45(2): 211-6. [22] NAKIMULI-MPUNGU E, MUSISI S, KATABIRA E, et al. Prevalence and factors associated with depressive disorders in an HIV+ rural patient population in southern Uganda [J]. Journal of affective disorders, 2011, 135(1-3): 160-7. [23] WU D Y, MUNOZ M, ESPIRITU B, et al. Burden of depression among impoverished HIV-positive women in Peru [J]. Journal of acquired immune deficiency syndromes (1999), 2008, 48(4): 500-4. [24] WAGNER G J, HOLLOWAY I, GHOSH-DASTIDAR B, et al. Understanding the influence of depression on self-efficacy, work status and condom use among HIV clients in Uganda [J]. Journal of psychosomatic research, 2011, 70(5): 440-8. [25] 石川, 于欣, 金华, 等. 云南美沙酮门诊静脉吸毒感染HIV患者神经认知、抑郁和自杀情况调查[C].中华医学会第九次精神病学全国学术会议论文集,2011:171. [26] 况伟宏, 李进, 马渝根, 等. HIV感染者/AIDS病人心理状况及生活质量调查 [J]. 四川大学学报(医学版), 2005(1): 97-100. [27] AMMASSARI A, ANTINORI A, ALOISI M S, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons [J]. Psychosomatics, 2004, 45(5): 394-402. [28] SPRINGER S A, DUSHAJ A, AZAR M M. The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review [J]. AIDS and behavior, 2012, 16(8): 2119-43. [29] REYNOLDS N R, TESTA M A, MARC L G, et al. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study [J]. AIDS and behavior, 2004, 8(2): 141-50. [30] HUYNH A K, KINSLER J J, CUNNINGHAM W E, et al. The role of mental health in mediating the relationship between social support and optimal ART adherence [J]. AIDS care, 2013, 25(9): 1179-84. [31] HIMELHOCH S, BROWN C H, WALKUP J, et al. HIV patients with psychiatric disorders are less likely to discontinue HAART [J]. AIDS (London, England), 2009, 23(13): 1735-42. [32] HIMELHOCH S, MEDOFF D R, OYENIYI G. Efficacy of group psychotherapy to reduce depressive symptoms among HIV-infected individuals: a systematic review and meta-analysis [J]. AIDS patient care and STDs, 2007, 21(10): 732-9. [33] 孙林岚,丁永军.心理护理结合健康宣教对艾滋病病人自我效能影响.实用预防医学,2014,21(6):762-764 [34] HOLSTAD M K, PACE J C, DE A K, et al. Factors associated with adherence to antiretroviral therapy [J]. The Journal of the Association of Nurses in AIDS Care : JANAC, 2006, 17(2): 4-15. [35] STIRRATT M J, REMIEN R H, SMITH A, et al. The role of HIV serostatus disclosure in antiretroviral medication adherence [J]. AIDS and behavior, 2006, 10(5): 483-93. [36] CONSERVE D F, KING G, DEVIEUX J G, et al. Determinants of HIV serostatus disclosure to sexual partner among HIV-positive alcohol users in Haiti [J]. AIDS and behavior, 2014, 18(6): 1037-45. [37] DO N T, PHIRI K, BUSSMANN H, et al. Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana [J]. AIDS research and human retroviruses, 2010, 26(6): 685-91.